These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38082914)

  • 21. Early detection of speech and voice disorders in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation: a 1-year follow-up study.
    Tsuboi T; Watanabe H; Tanaka Y; Ohdake R; Hattori M; Kawabata K; Hara K; Ito M; Fujimoto Y; Nakatsubo D; Maesawa S; Kajita Y; Katsuno M; Sobue G
    J Neural Transm (Vienna); 2017 Dec; 124(12):1547-1556. PubMed ID: 29098450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings.
    Sapir S; Spielman JL; Ramig LO; Story BH; Fox C
    J Speech Lang Hear Res; 2007 Aug; 50(4):899-912. PubMed ID: 17675595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frenchay dysarthria assessment (FDA-2) in Parkinson's disease: cross-cultural adaptation and psychometric properties of the European Portuguese version.
    Cardoso R; Guimarães I; Santos H; Loureiro R; Domingos J; de Abreu D; Gonçalves N; Pinto S; Ferreira J
    J Neurol; 2017 Jan; 264(1):21-31. PubMed ID: 27747392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of an extended version of the lee silverman voice treatment on voice and speech in Parkinson's disease.
    Spielman J; Ramig LO; Mahler L; Halpern A; Gavin WJ
    Am J Speech Lang Pathol; 2007 May; 16(2):95-107. PubMed ID: 17456888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Dysarthria across Parkinson's disease progression. Natural history of its components: dysphonia, dysprosody and dysarthria].
    Pinto S; Ghio A; Teston B; Viallet F
    Rev Neurol (Paris); 2010 Oct; 166(10):800-10. PubMed ID: 20800250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lee Silverman Voice Treatment for dysarthria in patients with Parkinson's disease: a systematic review and meta-analysis.
    Yuan F; Guo X; Wei X; Xie F; Zheng J; Huang Y; Huang Z; Chang Z; Li H; Guo Y; Chen J; Guo J; Tang B; Deng B; Wang Q
    Eur J Neurol; 2020 Oct; 27(10):1957-1970. PubMed ID: 32539227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in vocal intensity in Parkinson's disease following pallidotomy surgery.
    Schulz GM; Greer M; Friedman W
    J Voice; 2000 Dec; 14(4):589-606. PubMed ID: 11130116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences between Subjective and Objective Assessment of Speech Deficiency in Parkinson Disease.
    Pawlukowska W; Szylińska A; Kotlęga D; Rotter I; Nowacki P
    J Voice; 2018 Nov; 32(6):715-722. PubMed ID: 29122413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vocal tract characteristics in Parkinson's disease.
    Gillivan-Murphy P; Carding P; Miller N
    Curr Opin Otolaryngol Head Neck Surg; 2016 Jun; 24(3):175-82. PubMed ID: 26900819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term effects of Lee Silverman Voice Treatment on daily voice use in Parkinson's disease as measured with a portable voice accumulator.
    Körner Gustafsson J; Södersten M; Ternström S; Schalling E
    Logoped Phoniatr Vocol; 2019 Oct; 44(3):124-133. PubMed ID: 29447488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prosodic Improvement in Persons with Parkinson Disease Receiving SPEAK OUT!® Voice Therapy.
    Boutsen F; Park E; Dvorak J; Cid C
    Folia Phoniatr Logop; 2018; 70(2):51-58. PubMed ID: 29996139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Speech disorder and vocal tremor in postural instability/gait difficulty and tremor dominant subtypes of Parkinson's disease.
    Tykalová T; Rusz J; Švihlík J; Bancone S; Spezia A; Pellecchia MT
    J Neural Transm (Vienna); 2020 Sep; 127(9):1295-1304. PubMed ID: 32651925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease.
    Herd CP; Tomlinson CL; Deane KH; Brady MC; Smith CH; Sackley CM; Clarke CE
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD002812. PubMed ID: 22895930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of levodopa treatment in the voice pattern of Parkinson's disease patients: a systematic review and meta-analysis.
    Pinho P; Monteiro L; Soares MFP; Tourinho L; Melo A; Nóbrega AC
    Codas; 2018 Oct; 30(5):e20170200. PubMed ID: 30304100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Articulation disorders and duration, severity and L-dopa dosage in idiopathic Parkinson's disease.
    Pawlukowska W; Gołąb-Janowska M; Safranow K; Rotter I; Amernik K; Honczarenko K; Nowacki P
    Neurol Neurochir Pol; 2015; 49(5):302-6. PubMed ID: 26377981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysprosody and stimulus effects in Cantonese speakers with Parkinson's disease.
    Ma JK; Whitehill T; Cheung KS
    Int J Lang Commun Disord; 2010; 45(6):645-55. PubMed ID: 19995207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spectral/Cepstral Analyses of Phonation in Parkinson's Disease before and after Voice Treatment: A Preliminary Study.
    Alharbi GG; Cannito MP; Buder EH; Awan SN
    Folia Phoniatr Logop; 2019; 71(5-6):275-285. PubMed ID: 31117110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative analysis of speech impairment and upper limb motor dysfunction in Parkinson's disease.
    Rusz J; Tykalová T; Krupička R; Zárubová K; Novotný M; Jech R; Szabó Z; Růžička E
    J Neural Transm (Vienna); 2017 Apr; 124(4):463-470. PubMed ID: 27933492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acoustic investigation of stress patterns in Parkinson's disease.
    Tykalova T; Rusz J; Cmejla R; Ruzickova H; Ruzicka E
    J Voice; 2014 Jan; 28(1):129.e1-129.e8. PubMed ID: 24094802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neural Correlates of Hypokinetic Dysarthria and Mechanisms of Effective Voice Treatment in Parkinson Disease.
    Baumann A; Nebel A; Granert O; Giehl K; Wolff S; Schmidt W; Baasch C; Schmidt G; Witt K; Deuschl G; Hartwigsen G; Zeuner KE; van Eimeren T
    Neurorehabil Neural Repair; 2018 Dec; 32(12):1055-1066. PubMed ID: 30444176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.